Public Calendar: March 24-30, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 03/25/2019
Location: Silver Spring, MD
Subject: Youth Tobacco Prevention
FDA Participant/Group: LAUREN ROTH; ANN SIMONEAU; CARLYLE MCWILLIAMS; JOSEPHINE TROPEA; MICHELE MITAL; LAUREN SILVIS; MITCHELL ZELLER; AMY ABERNETHY; DAVID MEDNICK; ANNA ABRAM;
Non FDA Participant/Group: David Graham, Jeff Weiss, Ryan Nivakoff (NJOY);
Event Date: 03/27/2019
Location: Washington, DC
Subject: National Coalition for Cancer Survivorship: Cancer Policy Roundtable
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Government, industry, academia, and other invited guests
Event Date: 03/29/2019
Location: Washington, DC
Subject: Alliance for a Stronger FDA
FDA Participant/Group: LAUREN SILVIS; KATHLEEN QUINN;
Non FDA Participant/Group: Government, media, industry, and other invited guests
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 03/25/2019
Location: Silver Spring, MD
Subject: Global Teen Challenge: Building a Wide-Scale Addiction Recovery Dataset to Help Address the Opioid Epidemic
FDA Participant/Group: KRISTINE MORAN; LAUREN ROTH; DAYLE CRISTINZIO; EMILY HELMS WILLIAMS; JAMES FLAHIVE;
Non FDA Participant/Group: Gary Blackard, Tim Kincaid (Global Teen Challenge); Bill Dudley (Dudley Strategies);
Event Date: 03/27/2019
Location: Washington, DC
Subject: 2019 Health Datapalooza: Accomplishments of FDA's Digital Health Innovation Plan
FDA Participant/Group: SEAN KHOZIN; PAUL HOWARD; LONNIE SMITH;
Non FDA Participant/Group: Simmi Singh (Egon Zehnder International Ltd.), several members from AcademyHealth, the National Institutes of Health, and the Centers for Disease Control and Prevention
Event Date: 03/28/2019
Location: Washington, DC
Subject: Deloitte Women in Leadership Series
FDA Participant/Group: ANGELIQUE HEBERT;
Non FDA Participant/Group: N/A
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
Event Date: 03/29/2019
Location: Silver Spring, MD
Subject: FDA Drug Shortages Task Force Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Diane Hustead, Frank Reale, Kimberly Duffy (Merck Sharp & Dohme Corp.); Meredyth Andrus (Federal Trade Commission);
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 03/27/2019
Location: Boston, MA
Subject: 3rd Annual Gene Therapy for Rare Disorders Conference: Defining a Harmonized, Globally-Applicable Regulatory Framework for Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 03/28/2019
Location: Silver Spring, MD
Subject: Alliance for Regenerative Medicine/FDA Liaison Meeting
FDA Participant/Group: Several CBER officials and staff members
Non FDA Participant/Group: Several representatives from the Alliance for Regenerative Medicine
Event Date: 03/28/2019
Location: Boston, MA
Subject: 3rd Annual Gene Therapy for Rare Disorders Conference: FDA’s Efforts to Facilitate the Development and Availability of Gene Therapy Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 03/26/2019
Location: Washington, DC
Subject: EXCITE International Health Technology Global Summit: Changing U.S. Regulatory Landscape
FDA Participant/Group: MURRAY SHELDON;
Non FDA Participant/Group: N/A
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event